SD 900

Drug Profile

SD 900

Alternative Names: Deuterium-substituted tofacitinib; SD-900

Latest Information Update: 15 Jan 2015

Price : $50

At a glance

  • Originator Auspex Pharmaceuticals
  • Class 2 ring heterocyclic compounds; Amides; Nitriles; Organic deuterium compounds; Piperidines; Pyrimidines; Pyrroles; Small molecules
  • Mechanism of Action Immunosuppressants; Janus kinase 3 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 15 Jan 2015 Discontinued - Preclinical for Rheumatoid arthritis in USA (PO)
  • 15 Nov 2012 Preclinical trials in Rheumatoid arthritis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top